PTPA and gastric cancer: Protein phosphatase 2 (PP2A) and dual-specificity phosphatase (DUSP) expression were found to alleviate the oncogenic effects of SRPK1 expression in gastric cancer cells, though their exact inhibitory roles were not fully determined in this study [34].